| All Releases |
|---|
 |
EpiCept Corporation Names Rita Kelley Senior Director of Marketing
Jul 6, 2010
|
12.2 KB
|
| |
TARRYTOWN, N.Y., Jul 06, 2010 (BUSINESS WIRE) -- Regulatory News:
EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) announced
today that it has appointed Rita Kelley as the Company's Senior Director
of Marketing, a newly created position. A recognized leader in global
pharmaceutical and biotechnology marketing, Ms....
|
|
|
EpiCept Files New Drug Application for Ceplene in AML
Jun 29, 2010
|
13.5 KB
|
| |
TARRYTOWN, N.Y., Jun 29, 2010 (BUSINESS WIRE) -- Regulatory News:
EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) announced
today that it has submitted a New Drug Application (NDA) to the U.S.
Food and Drug Administration (FDA) for Ceplene(R) (histamine
dihydrochloride). EpiCept is seeking approval for Ceplene, a...
|
|
|
EpiCept to Present at the OneMedForum New York 2010
Jun 28, 2010
|
11.9 KB
|
| |
TARRYTOWN, N.Y., Jun 28, 2010 (BUSINESS WIRE) -- Regulatory News:
EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT)
today announced that Jack Talley, President and CEO, will be presenting
at the OneMedForum New York 2010 on June 30, 2010 at 9:00 a.m. EDT at
the Roosevelt Hotel in New York City. Mr. Talley...
|
|
|
EpiCept Announces Pricing of Public Offering
Jun 28, 2010
|
20.1 KB
|
| |
TARRYTOWN, N.Y., Jun 28, 2010 (BUSINESS WIRE) -- Regulatory News:
EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) announced
today that it entered into definitive agreements for the purchase of
approximately 6.1 million shares of its common stock at $1.10 per share,
five year warrants to purchase...
|
|
|
EpiCept Corporation Added to Preliminary List of Companies in Russell Microcap Index
Jun 15, 2010
|
12.3 KB
|
| |
TARRYTOWN, N.Y., Jun 15, 2010 (BUSINESS WIRE) -- Regulatory News:
EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) announced
today that the Company's common stock has been included on a list of
preliminary additions to the Russell Microcap(R) Index posted by Russell
Investments on June 11, 2010 on www.russell.com....
|
|
|
EpiCept Announces Fulfillment of Ceplene's Third European Post-Approval Commitment
Jun 1, 2010
|
13.8 KB
|
| |
TARRYTOWN, N.Y., Jun 01, 2010 (BUSINESS WIRE) -- Regulatory News:
EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT)
today provided an update on the post-approval commitments requested by
the European Medicines Agency (EMA) as part of its marketing
authorization for Ceplene(R) (histamine dihydrochloride). ...
|
|
|
EpiCept Announces Webcast of Annual Shareholder Meeting
May 28, 2010
|
12.0 KB
|
| |
TARRYTOWN, N.Y., May 28, 2010 (BUSINESS WIRE) -- Regulatory News:
EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT)
today announced that its annual shareholder meeting will be accessible
to investors via webcast. The annual meeting will be held on Thursday,
June 3, 2010, at 10:00 AM EDT at the IBM Palisad...
|
|
|
Targeted Patient Enrollment Reached in Phase IIb Clinical Trial for Epicept(TM) NP-1 in Chemotherapy-Induced Peripheral Neuropathy
May 26, 2010
|
12.9 KB
|
| |
TARRYTOWN, N.Y., May 26, 2010 (BUSINESS WIRE) -- Regulatory News:
EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT)
today announced that the targeted enrollment in a Phase IIb trial for
EpiCept(TM) NP-1 in chemotherapy-induced peripheral neuropathy (CPN) has
been attained. The trial is being conducted by ...
|
|
|
EpiCept Corporation Announces Commercial Launch of Ceplene(R) in Germany
May 21, 2010
|
12.6 KB
|
| |
TARRYTOWN, N.Y., May 21, 2010 (BUSINESS WIRE) -- Regulatory News:
EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT)
today announced the commercial launch of Ceplene (R)
(histamine dihydrochloride) in Germany. The launch is being conducted by
Meda AB, (OMX Nordic Exchange: MEDA-A-ST) as part of an exclusiv...
|
|
|
EpiCept to Present at the Rodman & Renshaw Annual Global Investment Conference
May 13, 2010
|
12.0 KB
|
| |
TARRYTOWN, N.Y., May 13, 2010 (BUSINESS WIRE) -- Regulatory News:
EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT)
today announced that Jack Talley, President and CEO, will be presenting
at the Rodman & Renshaw Annual Global Investment Conference on May 18,
2010 at 9:50 am local time at the Grosvenor Hou...
|
|
|
EpiCept Corporation Reports First Quarter 2010 Operating and Financial Results
May 6, 2010
|
28.3 KB
|
| |
TARRYTOWN, N.Y., May 06, 2010 (BUSINESS WIRE) -- Regulatory News:
EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT)
today announced operating and financial results for the three months
ended March 31, 2010, and provided an update with respect to the
Company's key business initiatives.
"Most recently, Epi...
|
|
|
EpiCept Earns $2 Million Milestone Payment from Meda AB
May 4, 2010
|
12.6 KB
|
| |
TARRYTOWN, N.Y., May 04, 2010 (BUSINESS WIRE) -- Regulatory News:
EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT)
today announced that it has earned a $2 million milestone payment from
Meda AB, (OMX Nordic Exchange: MEDA-A-ST), for the first commercial
shipment of Ceplene(R) (histamine dihydrochloride) ...
|
|
|
EpiCept to Report First Quarter 2010 Operating and Financial Results on May 6, 2010
May 3, 2010
|
12.4 KB
|
| |
TARRYTOWN, N.Y., May 03, 2010 (BUSINESS WIRE) -- Regulatory News:
EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT)
announced today that it will host a conference call to discuss first
quarter 2010 operating and financial results on Thursday, May 6, 2010 at
9:00 a.m. Eastern time. The call will follow the...
|
|
|
EpiCept to Present at the BIO International Convention
Apr 30, 2010
|
11.9 KB
|
| |
TARRYTOWN, N.Y., Apr 30, 2010 (BUSINESS WIRE) -- Regulatory News:
EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT)
today announced that Jack Talley, President and CEO, will be presenting
at the BIO International Convention on May 4, 2010 at 10:30 AM local
time at the McCormick Place Convention Center. Mr...
|
|
|
Notice of the Annual Meeting of Stockholders of EpiCept Corporation
Apr 23, 2010
|
15.2 KB
|
| |
TARRYTOWN, N.Y., Apr 23, 2010 (BUSINESS WIRE) -- Regulatory News:
With this notice, stockholders of EpiCept Corporation (Nasdaq and Nasdaq
OMX Stockholm Exchange: EPCT) are invited to the Annual Meeting of
Stockholders (the "Annual Meeting") on June 3, 2010, at 10:00 a.m.
Eastern time at the Dolce/IBM Palisades Executive Co...
|
|
|
EpiCept Announces Commercial Launch of Ceplene(R) in the United Kingdom
Apr 19, 2010
|
13.1 KB
|
| |
TARRYTOWN, N.Y., Apr 19, 2010 (BUSINESS WIRE) -- Regulatory News:
EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT)
today announced that the commercial launch of Ceplene(R)
(histamine dihydrochloride) will take place in the United Kingdom on
April 20, 2010 in conjunction with the British Society for Haema...
|
|
|
EpiCept to Present at 30th Annual Cowen and Company Health Care Conference
Mar 2, 2010
|
11.2 KB
|
| |
TARRYTOWN, N.Y., Mar 02, 2010 (BUSINESS WIRE) -- Regulatory News:
EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm: EPCT) announced
today that Jack Talley, President and CEO, will be presenting at the
Cowen and Company 30th Annual Health Care Conference on March 9, 2010 at
2:15 pm Eastern time at the Boston Marriott Cop...
|
|
|
EpiCept Reports Fourth Quarter Financial Results, Provides Business Update
Feb 25, 2010
|
31.4 KB
|
| |
TARRYTOWN, N.Y., Feb 25, 2010 (BUSINESS WIRE) -- Regulatory News:
EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT)
today announced operating and financial results for the fourth quarter
and year ended December 31, 2009, and provided an update on Ceplene(R) and
several of the Company's key product candida...
|
|
|
EpiCept to Report Fourth Quarter and Full Year 2009 Operating and Financial Results on February 25, 2010
Feb 22, 2010
|
11.4 KB
|
| |
TARRYTOWN, N.Y., Feb 22, 2010 (BUSINESS WIRE) -- Regulatory News:
EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm: EPCT) announced
today that it will host a conference call to discuss fourth quarter and
full year 2009 operating and financial results on Thursday, February 25,
2010 at 9:00 a.m. Eastern time. The call wil...
|
|
|
EpiCept Establishes At-the-Market Public Stock Offering Program
Feb 5, 2010
|
12.3 KB
|
| |
TARRYTOWN, N.Y., Feb 05, 2010 (BUSINESS WIRE) -- Regulatory News:
EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm: EPCT) announced
today that it has established an at-the-market program through which it
may sell, from time to time and at its sole discretion, shares of its
common stock having an aggregate offering price...
|
|
|
